Chemical industry split about the case for more US plants

| May 9, 2017

article image
The surge in investment into the US petrochemicals industry over the past seven years has bA series of giant new plants that will make chemicals used to produce plastics, from companies including Dow Chemical and ExxonMobil, are about to come online.

Spotlight

Euticals

Today's Euticals is one of the leading players in the pharmaceutical & fine chemicals industry with a global scale production and diversified manufacturing sites. All plants, located in Italy, France, Germany and USA are usually inspected by international and national regulatory agencies, such as FDA (acceptable with no 483), KFDA, ANVISA, etc. Banking on, also, the last acquisitions, Poli-Industria Chimica in 2010 and Archimica in 2011, Euticals purpose is to be the ideal partner for pharmaceutical and chemical companies satisfying any inquiry, coming from the API generic market and pharmaceutical research companies, covering the worldwide area. The strategic proposition is to develop innovative solutions and ensure high quality and competitive prices by continuously improving every process and manufacturing activity.

OTHER ARTICLES

Removal of non-industrial chemicals from the NICNAS Inventory

Article | March 23, 2020

The Australian Government announced its intention to implement reforms to the way in which industrial chemicals are regulated. The reforms are intended to streamline the process of assessing industrial chemicals to reduce the regulatory burden and to make regulatory effort more proportionate to risk. The Industrial Chemicals Act, which was passed by Parliament in February of 2019 and received Royal Assent in March of 2019, creates a new framework for the regulation of imported or manufactured industrial chemicals. The new scheme, referred to as the Australian Industrial Chemicals Introduction Scheme, or AICIS, will replace the current National Industrial Chemicals Notification and Assessment Scheme, referred to as NICNAS.

Read More

Coronavirus Impact on Fine Chemical Supply Chain

Article | March 6, 2020

Coronavirus, more accurately referred to as COVID-19, is beginning to impact global supply chains in a tangible way. Although it is impossible to forecast the effect of numerous epidemics worldwide on the fine chemical supply chain specifically, reports suggest that as much as 94% of the Fortune 1000 are already experiencing coronavirus-related supply disruptions. Fortune cites the devastating 2011 tsunami as a case study of how unforeseeable disasters can severely disturb supply chains with far-reaching ramifications. Damage to Mitsubishi Gas Chemical factories in the area affected by the tsunami led to a shortage of bismaleimide triazine (BT) resin; a critical material for electronic substrates.

Read More

What's the Most Toxic Chemical?

Article | February 24, 2020

People say America doesn’t make things anymore. But what about toxic chemicals? We make so many of those, we throw half of them in rivers, for free. The problem is, it can be hard to get a handle on which of those chemicals are extremely toxic and which of them are merely somewhat toxic. If one or another shows up in a scan of your stomach, should you freak out or just be grateful it wasn’t something worse? For this week’s Giz Asks, we reached out to a number of experts to find out what the most toxic chemical is.

Read More

Transporting biological and chemical materials - what you need to know

Article | February 13, 2020

The landscape of biological and chemical logistics has changed rapidly - as have the regulatory frameworks around it. What has not necessarily kept pace is the end-user understanding of the nature of these logistical processes, their opportunities and their constraints. Twenty years ago, the transmission of biological and chemical materials was limited to a small range of organisations: usually national and international research companies, hospitals, major university departments, police and military departments with forensic responsibilities.

Read More

Spotlight

Euticals

Today's Euticals is one of the leading players in the pharmaceutical & fine chemicals industry with a global scale production and diversified manufacturing sites. All plants, located in Italy, France, Germany and USA are usually inspected by international and national regulatory agencies, such as FDA (acceptable with no 483), KFDA, ANVISA, etc. Banking on, also, the last acquisitions, Poli-Industria Chimica in 2010 and Archimica in 2011, Euticals purpose is to be the ideal partner for pharmaceutical and chemical companies satisfying any inquiry, coming from the API generic market and pharmaceutical research companies, covering the worldwide area. The strategic proposition is to develop innovative solutions and ensure high quality and competitive prices by continuously improving every process and manufacturing activity.

Events